181 |
Zilver PTX Stent for CLI - Insights from the Japan Post Market Study |
Hiroyoshi Yokoi |
Apr. 21. 16 |
180 |
Infrapopliteal Atherectomy - Techniques and Devices |
Ravish Sachar |
Apr. 21. 16 |
179 |
The Promise of Regenerative Therapies for CLI |
Krishna Rocha-Singh |
Apr. 21. 16 |
178 |
Optimal Medical Therapy for the CLI Patient - Does It Make a Difference? |
John Robert Laird, Jr. |
Apr. 21. 16 |
177 |
CLI - Insights from the OLIVE Registry |
Osamu Iida |
Apr. 21. 16 |
176 |
Cost Effectiveness of Endovascular Procedures - Can We Afford These Expensive Technologies? |
Mark W. Burket |
Apr. 21. 16 |
175 |
Atherectomy Followed by Drug Coated Balloon Angioplasty - Is This the Holy Grail? |
Lawrence A. Garcia |
Apr. 21. 16 |
174 |
Endovascular Therapies for Resistant Hypertension - The ROX 1 Year Results |
Krishna Rocha-Singh |
Apr. 21. 16 |
173 |
EVAR - Evolving Techniques and Devices |
Robert Bersin |
Apr. 21. 16 |
172 |
Carotid Stenting for Asymptomatic Carotid Stenosis - Will ACT 1 Change Anything? |
Richard R. Heuser |
Apr. 21. 16 |